![]() | Only 14 pages are availabe for public view |
Abstract The main indications for vertebroplasty are intractable, intense pain adjacent to the level of the fracture (Hoffman et al., 2003). Selected patients should have severe focal midline pain at or adjacent to the level of the fracture, these patients should also have undergone a period of conservative management, typically lasting 6 to 12 weeks (Peh et al., 2008). Vertebroplasty can be performed safely in patients with spinal canal compromise. This procedure can reduce pain, increase vertebral body height, and decrease wedge angle without worsening of retropulsion (Hiwatashi et al., 2007). Vertebral augmentation as prophylaxis in patients who have osteoporosis is debated. It is regarded as a contraindication in some guidelines, yet some investigators advocate vertebral augmentation for patients at very high risk for fracture (Denaro et al., 2009). The transpedicular approach has been considered the safest, as the needle traverses only skin, soft tissues, and bone to enter the vertebral body. Injury to adjacent nerve roots, vessels, and the spinal cord is impossible if the needle track remains in the pedicle (Kallmes et al., 2004). The most dreaded complication of percutaneous vertebroplasty is probably cement extravasation into the spinal canal and neural foramina. This complication is often due to destruction of the posterior cortex of the vertebral body and of the medial or inferior cortex of the pedicle (Laredo et al., 2004) Conclusion: Vertebroplasty is a safe, inexpensive and effective interventional vertebral augmentation technique that provides pain relief and stabilization in carefully selected patients with severe back pain due to vertebral compression (Peh et al., 2008) |